TamilChangemakers route Sitta's Profile
Sitta Sittampalam
Senior Advisor at NCATS/NIH
Bethesda,   United States
Senior Advisor at NCATS/NIH
Dr. Sittampalam is a Senior Advisor to the director at the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH), Bethesda, MD, USA., and adjunct Associate Professor of Medicine at the Indiana University School of Medicine, Indianapolis, IN. He joined NCATS in 2011 as Project Manager for The Rare & Neglected Diseases (TRND) Program. In his current position works closely with NCATS director and senior administration in identifying and implementing public-private partnerships with academia, government and pharmaceutical and biotechnology organizations internationally. He spent ~23 years in discovery and development of biotherapeutics and small molecule drugs at Eli Lilly & Co, Indianapolis, IN., followed by 4 years as tenured professor of Pharmacology, Toxicology and Therapeutics at the University of Kansas Medical Center. During his tenure, he also served as the Deputy Director of the Institute of Advancing Medical Innovations (IAMI) focused on therapeutic development for commercialization
Interests
Science Teaching & community work
About me
Dr. Sittampalam is a Senior Advisor to the director at the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH), Bethesda, MD, USA., and adjunct Associate Professor of Medicine at the Indiana University School of Medicine, Indianapolis, IN. He joined NCATS in 2011 as Project Manager for The Rare & Neglected Diseases (TRND) Program. In his current position works closely with NCATS director and senior administration in identifying and implementing public-private partnerships with academia, government and pharmaceutical and biotechnology organizations internationally. He spent ~23 years in discovery and development of biotherapeutics and small molecule drugs at Eli Lilly & Co, Indianapolis, IN., followed by 4 years as tenured professor of Pharmacology, Toxicology and Therapeutics at the University of Kansas Medical Center. During his tenure, he also served as the Deputy Director of the Institute of Advancing Medical Innovations (IAMI) focused on therapeutic development for commercialization
Interests
Science Teaching & community work
close
Stories
Videos Podcasts